Aged mice were divided into control and treatment groups, with the latter receiving intraperitoneal injections of FOXO4-DRI at doses of 0.5 mg/mL and 5 mg/kg every other day for 30 days, while controls received PBS
Pickard JM, Zeng MY, Caruso R, Nunez G
Some studies show it may help fight inflammation, protect against cancer, prevent diabetes complications, and treat herpes
The 2006 inflammopharmacology trial designation work introduced PL 14736 as the early-development name for the same compound, with reported activity on gastric vascular response
H.KimY.et al (2009)
Results suggest it may influence gene expression that helps control abnormal growth, though this research is still early and exploratory